Blom D, Morrissey N J, Mesonero C, Coppage M, Fisher T, Zuo X J, Jordan S C, Orloff M S
Department of Surgery, University of Rochester School of Medicine and Dentistry, N.Y, USA.
Surgery. 1996 Aug;120(2):213-9; discussion 219-20. doi: 10.1016/s0039-6060(96)80290-x.
Chronic rejection is the leading cause of late graft loss in kidney transplantation. We tested the ability of mixed hematopoietic chimerism to prevent chronic renal allograft rejection in an established rat model and described possible mechanisms responsible for this tolerance.
Mixed hematopoietic chimerism was established in lethally irradiated F-344 rats by reconstitution with Lewis bone marrow. Four groups (n = 5 each) received orthotopic kidney transplants: (1) allograft controls, (2) isograft controls, (3) experimental chimeras, and (4) specificity control. After 120 days kidney grafts were examined histologically, immunohistochemically, and for cytokine interferon-gamma, interleukin-2 (IL-2), IL-4, and IL-10 gene transcripts by means of reverse transcriptase polymerase chain reaction techniques.
Allograft control group exhibited severe parenchymal fibrosis; isograft control and chimera groups failed to develop this lesion. Immunohistochemical analysis revealed increased CD8+ lymphocytes and ED-1+ monocyte-macrophages infiltrating the tubulointerstitium of control allografts. Interferon-gamma and IL-2 were absent in isografts. IL-4 was absent and IL-10 was positive in all grafts. Chimeras promptly rejected third-party allografts.
Induction of specific tolerance through mixed hematopoietic chimerism prevents chronic renal allograft rejection. These results support the hypothesis of an immunologic basis of chronic rejection and advance previous observations that the induction of specific tolerance enables long-term solid organ transplantation without the use of immunosuppression.
慢性排斥反应是肾移植术后晚期移植物丢失的主要原因。我们在已建立的大鼠模型中测试了混合造血嵌合体预防慢性肾移植排斥反应的能力,并描述了导致这种耐受的可能机制。
通过用Lewis骨髓重建,在接受致死性照射的F-344大鼠中建立混合造血嵌合体。四组(每组n = 5)接受原位肾移植:(1)同种异体移植对照组,(2)同基因移植对照组,(3)实验性嵌合体组,以及(4)特异性对照组。120天后,对肾移植物进行组织学、免疫组织化学检查,并通过逆转录聚合酶链反应技术检测细胞因子干扰素-γ、白细胞介素-2(IL-2)、IL-4和IL-10基因转录本。
同种异体移植对照组表现出严重的实质纤维化;同基因移植对照组和嵌合体组未出现此病变。免疫组织化学分析显示,对照组同种异体移植的肾小管间质中浸润的CD8 +淋巴细胞和ED-1 +单核细胞-巨噬细胞增加。同基因移植中不存在干扰素-γ和IL-2。所有移植物中均不存在IL-4且IL-10呈阳性。嵌合体迅速排斥第三方同种异体移植物。
通过混合造血嵌合体诱导特异性耐受可预防慢性肾移植排斥反应。这些结果支持慢性排斥反应具有免疫学基础的假说,并推进了先前的观察结果,即诱导特异性耐受可实现长期实体器官移植而无需使用免疫抑制剂。